ConforMIS appoints Mark Augusti president and CEO
The Company also expects that Mr. Augusti will be appointed to the Company’s Board of Directors following the commencement of his employment.
Mr. Augusti’s 27-year business career has been marked with executive management responsibility in medical technology sales, marketing and general management.
Mr. Augusti joined Integra LifeSciences Corporation (Integra) in April 2014 and is Integra's Corporate Vice President and President of Orthopedics and Tissue Technologies.
Prior to joining Integra, Mr. Augusti served as Chief Executive Officer at Bioventus LLC, from May 2012 to August 2013, and was a member of the company's Board of Directors during the same period.
Prior to that he spent nine years with Smith & Nephew Inc., from April 2003 to April 2012, in a series of leadership roles, including President of Smith & Nephew's Biologic Division, where he was appointed to lead Smith & Nephew's new biologics initiative.
He also served as Smith & Nephew's President of the Orthopaedic Trauma & Clinical Therapies Global Business and Senior Vice President and General Manager of the Trauma business. In 2000, Mr. Augusti joined J.P. Morgan Securities as a Vice President in the Private Funds group.
Prior to that, from 1987 to 2000, he spent 13 years at GE Medical Systems Inc., where he held various sales, marketing and strategic management roles, both in the U.S. and internationally.
Mr. Augusti received his M.B.A. from the UCLA Anderson School of Management and his B.S. in Computer Science and Economics from Duke University.
He will succeed current President and Chief Executive Officer, Philipp Lang, M.D. MBA, and Dr. Lang will continue to serve on the Board of the Company.